References
- Biering-Sorensen F, Nielans HM, Dorflinger T, et al. Urological situation five years after spinal cord injury. Scand J Urol Nephrol 1999; 33: 157–61.
- Wein AJ. Neuromuscular dysfunction of lower urinary tract. In: Walsh PC, Retik AB, Darracott Vaughan E Jr, editors. Campbell's urology. Philadelphia, PA: Saun-ders; 1998. p. 953–1006.
- Abrams P. Khoury S, Wein A, editors. Incontinence. 1st International Consultation on Incontinence. Plymouth, UK: Health Publications; 1999. p. 105–54.
- Schurch B, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin detrusor injections in the treatment of detrusor hyperreflexia. J Urol 1999; 163 (Suppl 4): 244.
- Reitz A, Stöhrer M, Kramer G, Del Popolo G, Charlier-Kastler E, Panneck J, et al. European experience of 200 cases treated with Botulinum-A toxin injections into the detrusor muscle for neurogenic incontinence. Eur Urol 2003; Suppl 2: 140.
- Abrams P. Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardization of terminology of lower urinary tract function: report from the Standardisa-tion Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–78.
- Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a alternative to anticholinergic drugs? Preliminary results. J Urol 2000; 164: 692.
- Siegel S, Castellan NJ Jr. Nonparametric statistics for behavioral sciences. New York: McGraw-Hill; 1988.
- Staehler M, Sauter T, Miller K. Long term results prove Botulinum toxin A injection in the m. detrusor vesicae to be an alternative to surgery in children with myelome-ningocele. Eur Urol 2003; Suppl 2: 140.
- Grosse JO, Kramer AEJJ, Löchner-Ernst D, St'ohrer M. Success of repeat detrusor injections of Botulinum A toxin in patients with severe neurogenic detrusor over-activity and incontinence. Eur Urol 2003; Suppl 2: 141.
- Leipold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders; current state of the art. Eur Urol 2003; 44: 165–74.
- Wyndale JJ, Van Dromme SA. Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 2002; 40: 599–600.